FDA Inspection
AustarPharma, LLCAustarPharma, LLC – FDA Inspection, Jun 22, 2017
Record Details
This FDA Inspection record concerns AustarPharma, LLC, with an inspection on June 22, 2017, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · ff5437cf-d90b-484a-b3f3-d1c17a53201a
Inspection Facts
- Inspection number
- 1015357
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of AustarPharma, LLC
9| Date | Classification | Office | Project area |
|---|---|---|---|
| December 4, 2024 | VAI | New Jersey District Office | Postmarketing Surveillance and Epidemiology: Human Drugs |
| April 5, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 11, 2019 | Not classified | New Jersey District Office | |
| May 23, 2018 | VAI | New Jersey District Office | Generic Drug Evaluation |
| January 5, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AustarPharma, LLC
- FDA Inspection 1236866 - 2024-12-04
- FDA Inspection 1201798 - 2023-04-05
- FDA Inspection 1080178 - 2019-02-11
- FDA Inspection 1052925 - 2018-05-23
- FDA Inspection 1037881 - 2018-01-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.